Product Information
HYDROCORTISONE BUTYR 0.1% OINT is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $2.1796 per GM under NDC 51672408306. Its NADAC has been published 372 times since Nov 28, 2013.
FDA first approved this application on Dec 27, 2004.
Strength
1 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672408306
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE BUTYRATEApproval Type
Generic (ANDA)
FDA Application
ANDA076842FDA Approved
12/27/2004
On Market Since
12/27/2004
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORTISONE BUTYR 0.1% OINT has been published 372 times since Nov 28, 2013, and over the history we have for it it has risen 73.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1796 per GM |
|---|---|
| All-time high | $3.2571 (May 11, 2016) |
| All-time low | $1.0946 (Jul 23, 2014) |
| 52-week high | $2.5088 |
| 52-week low | $2.1796 |
| Median price | $2.7423 |
| Average price | $2.4088 |
| Largest weekly change | +77.7% (Sep 17, 2014) |
| Weeks tracked | 372 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocortisone Butyrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORTISONE BUTYR 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORTISONE BUTYR 0.1% OINT, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $2.1796 per GM (NDC 51672408306), effective Sep 30, 2026.
How has the price of HYDROCORTISONE BUTYR 0.1% OINT changed over time?
Over the history we have for it, the NADAC for HYDROCORTISONE BUTYR 0.1% OINT has risen 73.0%. It has been tracked across 372 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCORTISONE BUTYR 0.1% OINT?
Since Nov 28, 2013, the NADAC for HYDROCORTISONE BUTYR 0.1% OINT has ranged from a low of $1.0946 (Jul 23, 2014) to a high of $3.2571 (May 11, 2016), with a median of $2.7423 per GM.
Are there cheaper alternatives to HYDROCORTISONE BUTYR 0.1% OINT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCORTISONE BUTYR 0.1% OINT, is $2.0418 per GM — about 6% below HYDROCORTISONE BUTYR 0.1% OINT.
Who manufactures HYDROCORTISONE BUTYR 0.1% OINT?
HYDROCORTISONE BUTYR 0.1% OINT (NDC 51672408306) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.